Bellus Health Inc. - A Gsk Company

This study looked at how the drug camlipixant, being tested for chronic cough, behaves in people with liver impairment compared to those with healthy livers. It involved 32 adults aged 18-75. The goal was to understand safety and drug levels, not to treat the cough itself.